Omnicell, Inc. (OMCL)
| Market Cap | 5.75B |
| Revenue (ttm) | 914.37M |
| Net Income (ttm) | 35.01M |
| Shares Out | 42.96M |
| EPS (ttm) | 0.79 |
| PE Ratio | 170.15 |
| Forward PE | 40.82 |
| Dividend | n/a |
| Dividend Yield | n/a |
| Trading Day | May 11 |
| Last Price | $133.74 |
| Previous Close | $129.91 |
| Change ($) | 3.83 |
| Change (%) | 2.95% |
| Day's Open | 128.60 |
| Day's Range | 127.11 - 135.90 |
| Day's Volume | 298,340 |
| 52-Week Range | 56.16 - 146.99 |
Omnicell's (OMCL) raises adjusted EPS guidance for 2021 , which buoys optimism.
Omnicell (OMCL) delivered earnings and revenue surprises of 23.88% and 2.65%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Shares of Omnicell (NASDAQ:OMCL) were flat in after-market trading after the company reported Q1 results. Quarterly Results Earnings per share increased 25.76% over the past year to $0.83, which beat th...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell, Inc. (Nasdaq:OMCL), a leading provider of medication management solutions and adherence tools for health systems and pharmacies, today announced that Sc...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Announces Financial Results for First Quarter 2021
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--EnlivenHealth Partners with Twilio to Accelerate Launch of Transformative Patient Communications Solutions
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Putting progress ahead of politics is just one lesson Omnicell CEO Lipps picked up while building the leader in a key corner of the health care business. The post Why Omnicell's CEO Puts Progress Over P...
Investors are optimistic about Omnicell (OMCL) owing to its progress with its three-legged strategic, which is driving growth and an impressive 2025 roadmap.
Omnicell's (OMCL) Autonomous Pharmacy vision receives another boost with the latest service adoption by Aultman.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Aultman Health Foundation to Enhance Medication Management with Omnicell's Central Pharmacy Dispensing Service
Omnicell (OMCL) expands its autonomous pharmacy portfolio with the acquisition of PSG's 340B Link business.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Release First Quarter 2021 Financial Results on April 29, 2021
Omnicell (OMCL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in t...
Omnicell (OMCL) reported earnings 30 days ago. What's next for the stock?
Omnicell (OMCL) is progressing in autonomous pharmacy space by expanding portfolio and investing in the digital cloud-based platform.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Appoints Christine Mellon as Chief People Officer
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Present at Upcoming Investor Conferences
Omnicell saw its IBD SmartSelect Composite Rating jump to 96 Friday, up from 94 the day before. The post Omnicell Sees Composite Rating Move Up To 96 appeared first on Investor's Business Daily.
Omnicell's (OMCL) fourth-quarter 2020 revenues rose 0.36% year over year to $249.2 million, improving 16.1% sequentially.
Omnicell, Inc. (OMCL) CEO Randall Lipps on Q4 2020 Results - Earnings Call Transcript
Shares of Omnicell (NASDAQ:OMCL) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 18.18% year over year to $0.91, which beat the esti...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Reports Fiscal Year, Fourth Quarter 2020 Results Record 2020 Total Product Bookings of $1+ billion Full Year 2020 Revenues of $892.2 million
Omnicell (NASDAQ:OMCL) releases its next round of earnings this Monday, February 01. Get the latest predictions in Benzinga's essential guide to the company's Q4 earnings report.
3 Top Medical Info Systems Stocks to Beat COVID-19 Resurgence Crisis
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--WVU Medicine Selects Omnicell One Intelligence Solution to Drive Better Pharmacy Inventory Management, Optimize Costs, Support Better Patient Care
Omnicell (OMCL) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Per the preliminary announcement, Omnicell (OMCL) projects 2020 total revenues to surpass its previous guidance.
Omnicell (OMCL) is well positioned to outperform the market, as it exhibits above-average growth in financials.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Announces Preliminary Fiscal Year 2020 Financial Results
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell's EnlivenHealth™ Reports Strong Customer Demand for New SaaS Technology Solution to Help Pharmacies Meet COVID-19 Vaccination Challenges
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Partner with Guy's and St Thomas' NHS Foundation Trust, London on Development of European Technology-Enabled Intelligence Centre
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Owensboro Health to Deploy Omnicell's Technology-Enabled Services to Improve Safety and Efficiency in Medication Management
After a solid 2x rise since March lows of this year, at the current price of around $115 per share, Omnicell stock (NASDAQ: OMCL), a medication management services provider, has reached its near term po...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Present at the J.P. Morgan 39th Annual Healthcare Conference
Omnicell (OMCL) saw a big move last session, as its shares jumped more than 5% on the day, amid huge volumes.
Baxter International has approached medication management software vendor Omnicell with a takeover bid, Reuters reported, citing people familiar with the matter. Baxter's offer is in excess of $120 per ...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Announces Latest Advancements in Automation, Intelligence, and Technology-Enabled Services at Omnicell Illuminate 2020
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Allegheny Health Network Partners with Omnicell to Drive Safety and Efficiency for Medication Management Across Western Pennsylvania Network
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell to Present at Upcoming Investor Conferences
Omnicell, Inc. (OMCL) CEO Randall Lipps on Q3 2020 Results - Earnings Call Transcript
Omnicell (OMCL) delivered earnings and revenue surprises of 20.00% and 2.39%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Shares of Omnicell (NASDAQ:OMCL) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share decreased 21.05% year over year to $0.60, which beat the es...
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Reports Third Quarter 2020 Results
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Lehigh Valley Health Network Chooses Omnicell Solutions to Enhance Clinical and Operational Outcomes and Streamline Medication Management
Omnicell (OMCL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Memorial Hospital at Gulfport Selects Omnicell Central Pharmacy Dispensing Service to Enhance Medication Safety and Dispensing
CPSI vs. OMCL: Which Stock Is the Better Value Option?
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Omnicell Launches EnlivenHealth™ to Aid Retail Pharmacies and Health Plans Improve Patient Adherence, Quality Measures, and Retention
NEW YORK--(BUSINESS WIRE)--Headline of release should read: Blue Wolf Capital Closes on Sale of Pharmaceutical Strategies Group’s 340B Business to Omnicell (instead of: Blue Wolf Capital Closes on Sale ...
About OMCL
Omnicell, Inc., together with its subsidiaries, provides medication management automation solutions and adherence tools for healthcare systems and pharmacies the United States and internationally. The company offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. It also provides p... [Read more...]
| Industry Health Information Services | IPO Date Aug 7, 2001 |
| CEO Randall Lipps | Employees 2,970 |
| Stock Exchange NASDAQ | Ticker Symbol OMCL |
Financial Performance
In 2020, Omnicell's revenue was $892.21 million, a decrease of -0.54% compared to the previous year's $897.03 million. Earnings were $32.19 million, a decrease of -47.51%.
Analyst Forecasts
According to 8 analysts, the average rating for Omnicell stock is "Buy." The 12-month stock price forecast is 151.13, which is an increase of 13.00% from the latest price.